Telehealth GLP-1 prescriptions
A telehealth service run by Brentmoor, Inc. that prescribes compounded semaglutide and tirzepatide and the four brand-name GLP-1 pens, with NAD+, sermorelin, glutathione and skincare on the side. Its headline 'from $139' is a first-month price.
We may earn a commission if you buy through the links to Pallas Health on this page, at no extra cost to you. That does not change how we grade or rank it, and Pallas Health did not write or approve this review.
quality claims we could confirm ourselves, rather than repeat from the vendor's marketing.
Compounded semaglutide and tirzepatide, Wegovy, Zepbound, Ozempic, Mounjaro, NAD+, sermorelin and compounded skincare.
From $139/month
From $179/month
Everything here is a prescription service that starts with a licensed clinician's review of your own health information. Compounded medications are made by a pharmacy against a prescription and are not FDA-approved or reviewed by the FDA for safety, effectiveness or quality. This entry describes what the brand offers and what we could check. It is not medical advice and not a recommendation to use it.
Every telehealth brand we rank gets the same five checks, read from its public pages on September 24, 2026. "Not met" means we did not find it, or the terms say otherwise, on the pages we could read. Price and commission play no part.
The pricing section gives first-month and ongoing prices: about $199 a month for semaglutide, $299 for tirzepatide.
Names Lion MD as its clinical partner network, with Dr. Ana Lisa Carr and Dr. Kelly Tenbrink.
Names six partner pharmacies on its clinical page: Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills.
Terms describe a six-month promise: refund if there is no net weight loss after following the plan.
No warning letter under this name in FDA's public database on September 24, 2026.
Graded by whether we could confirm it ourselves or are only repeating what the vendor states. A vendor's honesty about its own testing is a different question from what a published trial shows, so this is a separate scale from the evidence grades on our guides.
The pricing section explains it: compounded semaglutide is $139 for the first month, then $597 every 12 weeks ($199 per month on average), or about $159 per month on the annual plan. Compounded tirzepatide is $179 for the first month, then $897 every 12 weeks ($299 per month on average). The banner is a first-month price, not the ongoing cost.
Where the vendor states thisStated on the homepage. We could not confirm the figure independently.
Where the vendor states thisBoth are stated on the homepage. We did not test cancellation.
Where the vendor states thisFDA does not review compounded drugs for safety, effectiveness or quality before they are sold. In 2026 FDA warned 30 telehealth companies over claims implying sameness with approved drugs, and proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, so the legal footing of this category can change.
Ongoing cost is about $199 per month for semaglutide and $299 for tirzepatide on the standard plan, so compare that, not $139.
The first month is $139 for semaglutide and $179 for tirzepatide. After that it averages about $199 and $299 per month on the standard 12-week billing.
Every fact above traces to one of these pages, published by the vendor itself and checked on September 23, 2026. Vendor policy pages change without notice, so if something here looks out of date, it probably is.
Compare against
Open pricing, public COAs, strict research-only gate
